Thrombin as a common downstream target blocking both platelet and monocyte activation

Thromb Haemost. 2009 Feb;101(2):220-1.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Angioplasty, Balloon, Coronary / adverse effects*
  • Anticoagulants / therapeutic use*
  • Antigens, CD / blood
  • Cytokines / blood
  • Fibrinolytic Agents / therapeutic use*
  • Humans
  • Monocytes / drug effects*
  • Monocytes / immunology
  • Platelet Activation / drug effects*
  • Platelet Aggregation Inhibitors / therapeutic use
  • Platelet Membrane Glycoproteins / metabolism
  • Thrombin / antagonists & inhibitors*
  • Thrombin / metabolism
  • Thrombosis / blood
  • Thrombosis / etiology
  • Thrombosis / prevention & control*
  • Treatment Outcome

Substances

  • Anticoagulants
  • Antigens, CD
  • Cytokines
  • Fibrinolytic Agents
  • Platelet Aggregation Inhibitors
  • Platelet Membrane Glycoproteins
  • Thrombin